Search Results - "Kuzuya, K."

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102) by Katsumata, N, Yoshikawa, H, Kobayashi, H, Saito, T, Kuzuya, K, Nakanishi, T, Yasugi, T, Yaegashi, N, Yokota, H, Kodama, S, Mizunoe, T, Hiura, M, Kasamatsu, T, Shibata, T, Kamura, T

“…Background: A phase III trial was conducted to determine whether neoadjuvant chemotherapy (NACT) before radical surgery (RS) improves overall survival…”
Get full text

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging by TAKANO, M, KIKUCHI, Y, MORIYA, T, SUGIYAMA, T, YAEGASHI, N, KUZUYA, K, UEKI, M, TSUDA, H, SUZUKI, M, KIGAWA, J, TAKEUCHI, S, TSUDA, H

“…A retrospective analysis was performed to evaluate the clinical characteristics and prognostic factors in the patients with clear cell carcinoma (CCC) of the…”
Get full text

Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis by Matsuoka, H, Kabata, D, Taura, A, Matsui, T, Takahi, K, Hirano, F, Katayama, M, Okamoto, A, Suenaga, Y, Suematsu, E, Yoshizawa, S, Ohmura, K, Ito, S, Takaoka, H, Oguro, E, Kuzuya, K, Okita, Y, Udagawa, C, Yoshimura, M, Teshigawara, S, Harada, Y, Isoda, K, Yoshida, Y, Ohshima, S, Tohma, S, Saeki, Y

Get full text

Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study by Takano, M, Sugiyama, T, Yaegashi, N, Sakuma, M, Suzuki, M, Saga, Y, Kuzuya, K, Kigawa, J, Shimada, M, Tsuda, H, Moriya, T, Yoshizaki, A, Kita, T, Kikuchi, Y

“…Clear cell carcinoma (CCC) of the ovary has been recognized to show resistance to anticancer agents in the first-line chemotherapy. Our aim was to evaluate the…”
Get more information

Effects of Cobalt-Substitution of the Active Zinc Ion in Thermolysin on Its Activity and Active-Site Microenvironment by Kuzuya, Keiko, Inouye, Kuniyo

“…Thermolysin is remarkably activated in the presence of high concentrations (1-5 M) of neutral salts [Inouye, K. (1992) J. Biochem. 112, 335–340]. The activity…”
Get full text

Phase III randomized trial of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) versus RH for bulky stage I/II cervical cancer (JCOG 0102) by Katsumata, N., Yoshikawa, H., Hirakawa, T., Saito, T., Kuzuya, K., Fujii, T., Hiura, M., Tsunematsu, R., Fukuda, H., Kamura, T.

“…Abstract only 5013 Background: NAC may represent an alternative to conventional RH for locally advanced cervical cancer. We compared NAC followed by RH with RH…”
Get full text

Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences by KONDO, E, AKATSUKA, Y, NAWA, A, KUZUSHIMA, K, TSUJIMURA, K, TANIMOTO, M, KODERA, Y, MORISHIMA, Y, KUZUYA, K, TAKAHASHI, T

“…Retroviral vectors are the frequently applied gene delivery vehicles for clinical gene therapy, but specificity of the immunogenicity to the protein encoded by…”
Get full text

Effect of Salts on the Solubility of Thermolysin: A Remarkable Increase in the Solubility as Well as the Activity by the Addition of Salts without Aggregation or Dispersion of Thermolysin by Inouye, Kuniyo, Kuzuya, Keiko, Tonomura, Ben'ichiro

“…Thermolysin is remarkably activated in the presence of high concentrations (1–5 M) of neutral salts [Inouye, K. (1992) J. Biochem. 112, 335–340]. The activity…”
Get full text

Associations between tumor diameter and prognostic variables of epithelial ovarian cancer by Nakanishi, T, Nawa, A, Niwa, Y, Nakamura, S, Kuzuya, K

“…Associations of tumor diameter in epithelial ovarian cancer with clinical and pathological prognostic variables were investigated. The clinical and…”
Get more information

Association between menopausal state and prognosis of endometrial cancer by Nakanishi, T, Ishikawa, H, Suzuki, Y, Inoue, T, Nakamura, S, Kuzuya, K

“…The purpose of our study was to examine the menopausal state as an independent prognostic variable of endometrial cancer and determine the conditions under…”
Get more information

Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study by Kuzuya, K, Ishikawa, H, Nakanishi, T, Kikkawa, F, Nawa, A, Fujimura, H, Iwase, A, Arii, Y, Kawai, M, Hattori, S, Sakakibara, K, Sasayama, E, Furuhashi, Y, Suzuki, T, Mizutani, S

“…A multicenter, phase I study of combination therapy with paclitaxel and carboplatin for epithelial ovarian cancer was conducted to determine the safety and…”
Get full text

3-hour infusion of single-agent paclitaxel for recurrent ovarian cancer by Ishikawa, H, Nakanishi, T, Nawa, A, Suzuki, Y, Kuzuya, K

“…The clinical response, survival, and toxicity of a 3-h infusion of single-agent paclitaxel (175 mg/m2) for Japanese patients with recurrent ovarian cancer were…”
Get full text

The efficacy of mass screening for uterine cancer by Kuzuya, K, Ishikawa, H

“…Mass screening for uterine cancer, mainly by cytological examination, has been conducted since 1962. The total number of examinees has been increasing and has…”
Get more information

CA125 by Ariyoshi, Y, Kuwabara, M, Kuzuya, K

Get more information

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome by Kaku, Tsunehisa, Yoshikawa, Hiroyuki, Tsuda, Hitoshi, Sakamoto, Atsuhiko, Fukunaga, Masaharu, Kuwabara, Yoshinori, Hataeg, Masaki, Kodama, Shoji, Kuzuya, Kazuo, Sato, Shinji, Nishimura, Toshinobu, Hiura, Masamichi, Nakano, Hitoo, Iwasaka, Tsuyoshi, Miyazaki, Koji, Kamura, Toshiharu

“…Thirty-nine patients with endometrioid adenocarcinoma (EA) and atypical hyperplasia (AH) of the endometrium who received conservative treatment to preserve…”
Get full text

The impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: A retrospective Japan clear cell carcinoma study by Takano, M., Sugiyama, T., Yaegashi, N., Sagae, S., Kuzuya, K., Udagawa, Y., Tsuda, H., Suzuki, M., Goto, T., Kikuchi, Y.

“…Abstract only…”
Get full text

Phase III randomized trial of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) versus RH for bulky stage I/II cervical cancer: Update of Japan Clinical Oncology Group (JCOG) Protocol 0102 by Katsumata, N., Yoshikawa, H., Kobayashi, H., Saito, T., Kuzuya, K., Mizunoe, T., Hiura, M., Kasamatsu, T., Shibata, T., Kamura, T.

“…Abstract only…”
Get full text

Effects and limitations of treatment of diabetes. On insulin secretory capacity (author's transl) by Kuzuya, K

Get more information

Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects by Niwa, Yoshimitsu, Matsuo, Keitaro, Ito, Hidemi, Hirose, Kaoru, Tajima, Kazuo, Nakanishi, Toru, Nawa, Akihiro, Kuzuya, Kazuo, Tamakoshi, Akiko, Hamajima, Nobuyuki

“…In this study, genetic polymorphisms, XRCC1 Arg399Gln and OGG1 Ser326Cys were examined with reference to cervical cancer risk in a population-based incident…”
Get full text

A Comparison of Prognoses of Pathologic Stage Ib Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix by Nakanishi, Toru, Ishikawa, Hisatake, Suzuki, Yuka, Inoue, Takeo, Nakamura, Shigeo, Kuzuya, Kazuo

“…Objectives. The influence of the histology of adenocarcinoma on recurrence and survival for patients treated with radical hysterectomy and diagnosed as having…”
Get full text